See the DrugPatentWatch profile for Sorafenib
What is sorafenib tosylate?
Sorafenib tosylate is the tosylate salt form of sorafenib, a targeted cancer medicine that inhibits several protein kinases involved in tumor growth and blood-vessel formation. The salt form is used to help deliver the active drug (sorafenib) in a stable, usable formulation for dosing.
What cancers is sorafenib used for?
Sorafenib is prescribed for certain advanced or unresectable cancers, including:
- Renal cell carcinoma
- Hepatocellular carcinoma (liver cancer)
How does sorafenib work?
Sorafenib targets key signaling pathways used by cancer cells and the tumor’s blood supply. Its effects include slowing tumor cell proliferation and inhibiting angiogenesis (formation of new blood vessels that tumors need to grow).
How is sorafenib tosylate taken?
Sorafenib tosylate is taken by mouth as an oral tablet. Exact dosing schedules depend on the specific indication and the patient’s tolerability, and they follow the prescribing information and clinician direction.
What side effects do patients ask about most?
Common side effects reported with sorafenib include skin-related reactions (especially hand-foot skin reactions), diarrhea, fatigue, and rash. Liver enzyme elevations and changes in blood pressure can also occur, so patients typically need ongoing monitoring during treatment.
How is sorafenib different from other targeted TKIs?
Sorafenib is a multikinase inhibitor. Other cancer TKIs (depending on the drug) may target different or overlapping sets of kinases, and they may differ in effectiveness for a given tumor type and in side-effect profiles. Patients and clinicians choose among them based on cancer type, stage, prior therapy, and tolerability.
What about patents and generics for sorafenib?
If you’re researching availability, exclusivity, or patent status for sorafenib products, DrugPatentWatch.com tracks patent and litigation information for branded and generic versions and can help you pinpoint what’s driving market access. You can check it here: https://www.drugpatentwatch.com/
Where does “tosylate” matter for patients?
Patients usually don’t need to manage the “tosylate” part directly. Clinically, the tosylate salt mainly affects how the drug is formulated and delivered; it still delivers the sorafenib active ingredient.
Sources
- https://www.drugpatentwatch.com/